Jyoti Ltd announced that the BSE has rejected its application to list 5,963,636 equity shares. This follows a long-standing dispute regarding the 2018 share allotment to Rare Asset Reconstruction Ltd, which previously faced opposition from the exchange and subsequent legal dismissals despite a 2025 ratification attempt.
Jyoti Ltd Listing Application Rejected by BSE
BSE rejects fresh listing application for 5,963,636 equity shares.
Management confirms no financial implications following the October 12, 2026, order.
Reader Takeaway: The listing of disputed shares remains stalled despite a 2025 shareholder ratification and prior legal appeals.
What just happened
Jyoti Ltd informed the exchanges that the Bombay Stock Exchange (BSE) has officially rejected its fresh application to list 5,963,636 equity shares. This order, dated October 12, 2026, marks the second unsuccessful attempt by the company to bring these specific shares to the trading platform.
The backstory
The core issue stems from an allotment of 5,963,636 equity shares made to Rare Asset Reconstruction Ltd on May 2, 2018. The BSE initially declined the listing of these shares, citing the lack of prior shareholder approval for the allotment. The company attempted to challenge this via the Securities Appellate Tribunal (SAT), which upheld the BSE's decision, followed by a failed appeal to the Supreme Court of India.
What changes now
In a move to resolve the compliance gap, the company conducted a postal ballot in May 2025, where shareholders passed a special resolution to ratify the 2018 allotment. Armed with this approval, the company filed for a fresh listing on May 31, 2026. However, the exchange has maintained its position with this latest rejection. Management stated there are no direct financial impacts from the order and is currently evaluating further regulatory or legal avenues.
Risks to watch
Investors should monitor the regulatory relationship between the company and the exchange. Continued inability to list these shares may keep a portion of the equity locked, affecting liquidity and corporate governance perceptions until the regulatory impasse is resolved.
